Bulk Alpha Lipoic Acid Powder for Advanced Cellular Energy Supplements

Alpha Lipoic Acid Overview

Alpha Lipoic Acid (ALA), also known as thioctic acid or 1,2-dithiolane-3-pentanoic acid, is an organosulfur compound with the molecular formula C8H14O2S2, a molecular weight of 206.33 g/mol and CAS registry number 1077-28-7. It is supplied as a fine yellow crystalline powder, standardized to 99% assay by HPLC, for metabolic-health, antioxidant and cellular-energy supplement manufacturing.

ALA is amphiphilic, functioning in both aqueous and lipid environments, which underpins its reputation as the "universal antioxidant." It acts as an essential cofactor in mitochondrial energy metabolism and is recognized by the NIH Office of Dietary Supplements and other regulatory bodies as a well-studied dietary ingredient for supporting healthy glucose metabolism and cellular defense.

The ingredient is available as standard DL-ALA, a racemic 50/50 mixture offering a cost-effective solution for general antioxidant formulations, and as R-ALA, the biologically active enantiomer with superior systemic bioavailability for premium-positioned products.

From a procurement standpoint, alpha lipoic acid is a stable, cost-efficient ingredient manufactured at scale in GMP-certified facilities, with a single qualified specification supporting capsule, tablet and powder product lines across multiple markets. Its well-documented safety profile and established monograph coverage make supplier qualification straightforward for formulators entering the metabolic-health category.

ALA has been studied for several decades, and its mechanism of action is comparatively well understood: the molecule is reduced inside cells to dihydrolipoic acid, and this redox pair drives much of its antioxidant and cofactor activity. For B2B buyers, this depth of published research reduces regulatory and marketing risk relative to less-characterized ingredients.

Source & Ingredient Identity

Purecium Alpha Lipoic Acid is 100% synthetic, manufactured by a defined chemical route from ethyl 6,8-dichlorooctanoate as the starting material. Synthetic production provides supply-chain resilience, consistent pricing and full traceability independent of botanical harvest cycles.

Two specification options are offered: DL-alpha-lipoic acid (racemic) and R-alpha-lipoic acid, both food grade with a minimum assay of 99% by HPLC. Identity is confirmed against compendial reference standards, with the finished material meeting food-grade release criteria aligned to USP-NF expectations.

The ingredient is verified non-GMO and free from major allergens. Both isomer grades are manufactured to the same food-grade framework, so buyers can select DL-ALA or R-ALA for cost or labeling strategy without changing finished-product handling.

Key Characteristics of Alpha Lipoic Acid

Key characteristics of Purecium Alpha Lipoic Acid include its fine yellow crystalline powder form, water solubility of approximately 0.9 g/L at 20 degrees Celsius, and defined assay, heavy-metal and residual-solvent profile. Release limits include lead below 0.5 ppm, arsenic below 3 ppm and strict control of residual solvents in line with USP and EU expectations.

ALA is processed for optimal flowability and bulk density, ensuring consistent filling weight and preventing bridging during high-speed encapsulation and automated tableting. The powder is heat-sensitive, and Purecium provides formulation guidance on low-temperature processing and pairing with stable excipients in finished dosage forms.

Physical and chemical data, including particle-size distribution, melting behavior, solubility and stability, are documented in the product specification sheet, and the powder is stable under standard ambient storage in sealed food-grade packaging away from light and heat.

For contract manufacturers running high-speed filling lines, the engineered powder flow properties reduce rejects and support content-uniformity targets in both two-piece hard capsules and compressed tablets, which is a documented advantage of the Purecium specification.

Alpha Lipoic Acid Manufacturing

Purecium Alpha Lipoic Acid is manufactured through a defined synthetic route in facilities certified under ISO 9001, FSSC 22000, Kosher and Halal food-safety programs. Production covers synthesis, oxidation and cyclization of the starting material, purification, crystallization, drying and sieving to specification. Each stage is governed by written standard operating procedures, and environmental monitoring supports consistent output across campaigns.

In-process checks, documented cleaning and changeover procedures, and batch numbering provide full traceability from ethyl 6,8-dichlorooctanoate starting material to finished drums. The R-ALA grade is produced through an additional enantioselective step to deliver the biologically active isomer.

Manufacturing capacity and lead times are managed to support both pilot-scale evaluation orders and ongoing contract manufacturing programs, with stability data supporting standard ambient shelf life in sealed packaging.

Applications of Alpha Lipoic Acid

Alpha lipoic acid is used across metabolic-health, blood-sugar-support, anti-aging and cognitive-wellness product categories. Published clinical research and peer-reviewed studies have examined ALA for supporting healthy glucose metabolism and insulin sensitivity, making it a leading active in metabolic wellness formulations.

As a potent antioxidant, ALA directly scavenges free radicals and regenerates other endogenous antioxidants including vitamin C, vitamin E and glutathione. This unique recycling activity supports cellular defense and healthy-aging positioning in daily wellness and longevity products.

The ingredient is a standard component of mitochondrial-support, energy and sports-nutrition formulas, where it is often combined with acetyl-L-carnitine, CoQ10 and B-vitamin complexes targeting cellular energy metabolism.

Its defined powder properties support a wide range of finished formats: capsules and tablets for daily metabolic and antioxidant supplements, and powder blends for effervescent and stick-pack products, including both standard DL-ALA and premium R-ALA lines.

In neurological and vision-support segments, R-ALA is frequently combined with other bioenergetic ingredients in formulas targeting healthy nerve function and ocular antioxidant defense, reflecting the ingredient's expanding use beyond core metabolic positioning.

Regulatory references for ALA are mature: the ingredient is recognized in multiple pharmacopoeias and food-additive frameworks, and analytical methods follow current USP-NF and European Pharmacopoeia monographs, giving finished-product brands a predictable compliance path across major markets.

Manufacturing & Quality Control

Quality control for Purecium Alpha Lipoic Acid operates under ISO 9001 and FSSC 22000 food-safety systems in strictly audited GMP facilities. Every production lot is released only after identity confirmation, HPLC assay, heavy-metal analysis, residual-solvent testing and microbiological examination, with analytical methods aligned to current USP-NF compendial practice.

Batch-to-batch consistency is guaranteed for both DL and R configurations, and the material is processed to meet global pharmaceutical-grade standards, with heavy metals and residual solvents strictly monitored for compliance with EU, USP and California Proposition 65 requirements.

Buyers receive a Certificate of Analysis, SDS and specification documentation with each shipment, and facility audits, batch records and additional technical documents are available during supplier qualification.

Alpha Lipoic Acid for B2B Supplement Manufacturing

Purecium supplies bulk Alpha Lipoic Acid to dietary supplement manufacturers, distributors, contract manufacturers and finished-product brands worldwide. Standard packaging is 25 kg per drum, with a flexible low MOQ starting at 25 kg for pilot and launch volumes.

The DL-ALA and R-ALA specification options give buyers procurement flexibility: cost-effective racemic material for mainstream antioxidant formulas or premium R-ALA for clinically positioned products, both with documented supply-chain resilience and consistent quality.

Technical support covers isomer selection guidance, formulation guidance for capsules, tablets and powder blends, specification alignment and the documentation needed for supplier qualification in target markets. Samples for R&D evaluation are available on request, and bulk orders are dispatched by air or sea freight with full export documentation.

Purecium maintains retained samples and complete batch records for each production lot, supporting customer audit programs, regulatory inquiries and long-term quality review throughout the product lifecycle.

Reviewed by the Chief Quality Assurance / Regulatory Affairs Specialist at Purecium for technical accuracy and regulatory alignment.